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Summary Coronary artery spasm plays an important role in the pathogenesis of angina pec-
toris as well as acute coronary syndrome and sudden death. The prevalence of coronary spasmEndothelium;
Vascular smooth
muscle;
Vascular failure
is greater in East Asian populations than in other parts of the world. Although the mechanism
of coronary spasm is still unclear, both endothelial and smooth muscle dysfunction have been
reported to play a role. We recently proposed a new concept termed ‘vascular failure’ that rep-
resents an integration of endothelial and smooth muscle abnormalities. Thus, vascular failure
is the primary cause of coronary artery spasm.
© 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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ntroduction
ngina pectoris is a clinical syndrome caused by transient
nitroglycerin administration; and (II) the attack is associated
with ST-segment depression on the electrocardiogram.
Coronary spasm plays an important role in angina pec-
yocardial ischemia due to an imbalance between the
yocardial oxygen supply and demand. Classical or exer-
ional angina is characterized by the following features: (I)
he attack is induced by exertion and relieved by rest or
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oi:10.1016/j.jjcc.2010.08.007oris as well as acute coronary syndrome [1]. Coronary
pasm is deﬁned as abnormal contraction of an epicardial
oronary artery resulting in myocardial ischemia (Fig. 1).
he manifestations commonly associated with myocardial
schemia are chest discomfort and ST elevation or depression
n the electrocardiogram. ST elevation denotes transmural
yocardial ischemia, whereas ST depression indicates non-
ransmural or subendocardial ischemia. The most sensitive
arker of myocardial ischemia is the appearance of a wall
otion abnormality, which can be detected by echocardio-
Published by Elsevier Ltd. All rights reserved.
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mFigure 1 Representative
graphy [2]. The production of lactate is a metabolic marker
of myocardial ischemia [3].
To evaluate the incidence of coronary spasm in Japanese
patients with angina pectoris, we investigated 2195 patients
with angina who were consecutively admitted to one of the
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Figure 2 Prevalence of coe of coronary spasm [36].
ajor institutes in Japan from 1998 to 1999 (mean age,
5.2 years). Of the 2195 patients with angina, 921(42%)
ad coronary spasm. The number of patients with angina
ectoris increases with an increase in age. The mean
ge of the patients with coronary spasm was 62.5± 10.3,
ronary spasm in Japan.
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vigure 3 Age distribution of coronary spastic angina and sta-
le effort angina in Japanese patients with angina pectoris.
hereas that of the patients with stable effort angina
as 67.0± 9.2 (p < 0.01). The age distribution was rela-
ively younger in the patients with coronary spasm than
n those with stable effort angina (Figs. 2 and 3). The
revalence of hypertension, diabetes mellitus, and low
igh-density lipoprotein (HDL)-cholesterol was lower in the
atients with coronary spasm than in those with stable
ffort angina (hypertension, 39.8% vs. 49.0%; diabetes,
2.4% vs. 23.2%; low HDL cholesterol, 16.6% vs. 30.6%;
< 0.01). In contrast, the proportion of smokers was higher
n the patients with coronary spasm than in the patients
ith stable effort angina (42.6% vs. 32.6%, p < 0.01). Most
f the patients with coronary spasm did not have signif-
cant ﬁxed coronary stenosis, whereas all patients with
table effort angina had signiﬁcant ﬁxed coronary stenosis
Table 1).ascular failure
therosclerosis is a progressive disease characterized by
he response of the vessel wall to chronic, multifactorial
c
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Table 1 Characteristics of patients with coronary spasm or stabl
Coronary spasm (n = 921)
Age (years) 62.5± 10.3
Sex (men) 607(65.9%)
Hypertension 367(39.8%)
Diabetes 114(12.4%)
Hypercholesterolemia 216(23.5%)
Low HDL-cholesterolemia 153(16.6%)
Hypertriglyceridemia 264(28.7%)
Smoker 392(42.6%)
Obesity 242(26.3%)
Family history 142(15.4%)
Coronary stenosis
No stenosis 83.1%
Single vessel 12.6%
Multivessel 4.3%
HDL, high-density lipoprotein.H. Kawano, K. Node
njury that ultimately leads to the formation of athero-
atous or ﬁbrous plaques. We recently proposed a new
oncept termed ‘vascular failure’ that represents an inte-
ration of the endothelial and smooth muscle abnormalities
4] (Fig. 4).
It is now well recognized that endothelial dysfunc-
ion is the initial stage of atherosclerosis. Endothelial
ysfunction is characterized by an impairment of the
alance between endothelium-derived relaxing factors
nd endothelium-derived constricting factors [5,6]. Thus,
ndothelial dysfunction is not only the initial stage of
therosclerosis but also plays a key role in angina pectoris
nduced by coronary spasm.
ndothelial function in coronary spasm
he endothelium is a ﬂat monolayer of cells that covers
he vascular lumen throughout the human body. Endothe-
ial cells are not merely constituents of the vessel wall,
ut play important roles in several biological processes [7].
hus, the vascular endothelium has been characterized as
multifunctional organ that it is essential to normal vascu-
ar physiology and plays a critical role in the pathogenesis
f vascular disease. In fact, there are several studies that
how that endothelial dysfunction is an independent pre-
ictor of cardiovascular events [8—10]. The presence of
ndothelial dysfunction is an essential component of vas-
ular failure.
Acetylcholine causes vasodilation by releasing nitric
xide or closely-related substances [5,6]. Coronary spasm
an be induced by methacholine or acetylcholine in
atients with coronary spasm via muscarinic receptors
11,12] (Table 2). In humans, acetylcholine, serotonin, his-
amine, and ergonovine are all endothelium-dependent
asodilators, since they release nitric oxide and induce
oronary dilation in young healthy subjects; however,
hey cause vasoconstriction in patients with atherosclero-
is [6,13—15]. Thus, patients with coronary spasm have a
isturbance in endothelial function of the coronary arteries
16].
e effort angina.
Stable effort angina (n = 1274)
67.0± 9.2 <0.0001
896(70.3%) <0.05
624(49.0%) <0.0001
296(23.2%) <0.0001
311(24.4%) NS
390(30.6%) <0.0001
401(31.5%) NS
465(36.5%) 0.004
350(27.5%) NS
208(16.3%) NS
0% <0.0001
36.7% <0.0001
63.3% <0.0001
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Figure 4 Schema of mechan
Smoking is closely associated with coronary spasm [17],
but the mechanism(s) is still unclear. In animal models,
cigarette smoke extract suppressed acetylcholine-induced,
endothelium-dependent dilation, and this suppression was
prevented by antioxidants or superoxide dismutase [18—20].
Thus, smoking reduces nitric oxide activity via oxygen-
derived free radicals contained in cigarette smoke [21,22].
Both basal and acetylcholine-induced coronary endothelial
dysfunction are improved by the intracoronary injection of
vitamin C, an antioxidant, in patients with coronary spasm
[23]. Vitamin E concentration is relatively low in patients
with coronary spasm as compared with healthy subjects
Table 2 Precipitating factors for coronary spasm.
1. Physiological factors
(1) Rest
(2) Physical and emotional stress
(3) Coronary spasm
(4) Straining
(5) Exposure to cold
(6) Hyperventilation
(7) Aging
(8) Others
2. Pharmacological agents
(1) Catecholamines (epinephrine/norepinephrine,
dopamine/dobutamine, etc.)
(2) Parasympathomimetic agents (acetylcholine,
methacholine, etc.)
(3) Anticholinesterase agents (physostigmine, neostigmine,
etc.)
(4) Ergot alkaloids (ergonovine, ergotamine, etc.)
(5) Others (serotonin, prostaglandins, histamine, smoking,
CaCl2, Tris-buffer, etc.)
3. Genetic factors
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24], and vitamin E administration is an effective treatment
or coronary spasm [25]. Thus, administration of antioxi-
ants in addition to conventional treatment is beneﬁcial for
oronary spasm.
Insulin resistance has been reported to play an impor-
ant role in the pathogenesis of coronary heart disease
26,27]. Insulin causes endothelium-dependent vasodilation
y releasing nitric oxide [28], and endothelium-dependent
asodilation is impaired in patients with insulin resis-
ance [29]. Insulin sensitivity and endothelial function are
ecreased by cigarette smoking, and antioxidants such as
itamin C improve insulin sensitivity and endothelial func-
ion in smokers [30]. The decreased endothelium-dependent
asodilation observed in these subjects may result from the
nactivation of endothelium-derived nitric oxide by reactive
xygen species [31]. The fasting glucose levels were not
ifferent between patients with coronary spasm and con-
rols, whereas fasting insulin levels were higher in patients
ith coronary spasm than in controls [32]. Insulin sen-
itivity, as assessed by the steady state plasma glucose
ethod, was impaired in patients with coronary spasm
ompared with controls. Antioxidants, such as vitamin C,
an improve insulin sensitivity and endothelial function in
atients with coronary spasm. Thus, reactive oxygen species
nd/or decreased nitric oxide bioactivity may play impor-
ant roles in the genesis of both endothelial dysfunction and
nsulin resistance in patients with coronary spasm.
The endothelium plays an important role in the regula-
ion of blood ﬂow to insulin-sensitive tissues, and insulin
nduces endothelium-dependent vasodilation [28,32]. Reac-
ive oxygen species cause endothelial dysfunction that may
ontribute to insulin resistance through impaired delivery
f insulin to insulin-sensitive tissues such as skeletal muscle
33]. In addition, it is possible that reactive oxygen species
ay cause ﬂow-independent insulin resistance by inhibiting
nsulin receptor signaling [34].
6C
C
i
m
h
c
m
i
a
s
c
t
v
w
M
m
m
l
S
C
s
[
h
a
a
t
[
C
C
g
a
e
s
T
e
h
ﬁ
t
R
[
[
[
[
[
[
[
[
[
[
[
[
[oronary smooth muscle in coronary spasm
ontraction of vascular smooth muscle depends on an
ncrease of intracellular calcium ions [35]. Coronary smooth
uscle of patients with coronary spastic angina shows a
ypercontractile response to various stimuli such as acetyl-
holine or histamine [11,12,16,20,36]. This phenomenon
ay be caused by increased smooth muscle cell mass and/or
ncreased receptor activation. Increased intimal thickening
nd hyperplasia of coronary arteries is involved in coronary
pastic angina [37,38]. The phosphorylation of myosin light
hain is the initial step for vascular smooth muscle con-
raction [35]. The contraction of coronary arteries occurs
ia Ca2+/calmodulin-activated myosin light chain kinase
ith subsequent phosphorylation of myosin light chain [35].
yosin light chain phosphorylation is augmented in ani-
al models with vascular spasm [39]. Rho-kinase augments
yosin phosphorylation by inhibiting myosin phosphatase,
eading to contraction of vascular smooth muscle [40].
himokawa and colleagues reported that protein kinase
and Rho-kinase activity were augmented in coronary
mooth muscle of animal models with coronary spasm
41]. Thus, coronary spasm can also be regarded as a
ypercontraction of coronary smooth muscle induced by
n increase of intracellular calcium ions [42,43]. Calcium
ntagonists, which can block the entry of calcium ions into
he cell, are very effective in suppressing coronary spasm
44].
onclusions
oronary spasm plays an important role in the patho-
enesis of ischemic heart disease in general, including
cute coronary syndromes. Acetylcholine, which is an
ndothelium-dependent vasodilator, can provoke coronary
pasm possibly due to the presence of injured endothelium.
hus, patients with coronary spasm have a disturbance in
ndothelial function of the coronary arteries as well as a
ypercontractile response of vascular smooth muscle. These
ndings suggest that vascular failure plays a crucial role in
he pathogenesis of coronary spasm.
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